Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
22.54 USD | +0.63% | -0.27% | +120.61% |
Jun. 02 | Transcript : Cullinan Therapeutics, Inc. - Special Call | |
Jun. 01 | Cullinan Therapeutics, Inc. Announces Positive Initial Data from Pivotal Phase 2b Rezil1 Study of Zipalertinib | CI |
- Stock Market
- Equities
- CGEM Stock
- News Cullinan Therapeutics, Inc.